India Pharma Outlook Team | Wednesday, 08 July 2026
The need for three-layer drug testing rises as low quality and contaminated medicines have become repeated incidents in the healthcare system in India.
This leads to growing scrutiny of the system. Therefore, the need to check the quality of drugs has become stricter in the recent tragic incidents.
In response to a series of maternal deaths connected with suspected drug failures, the Rajasthan government has announced a three-layer drug testing system. This is a huge change in the direction of pharmaceutical safety measures.
This shift is a sign of how states are increasingly realizing the importance of ensuring the quality of medicines as well as their availability. As people rely more on public healthcare systems and free drug schemes, it is important that multi-level testing is at the heart of protecting lives.
Drug quality testing is crucial in safe healthcare delivery. A three-layer testing system ensures that medicines are checked at multiple stages of procurement, distribution, and administration. This minimizes the chances of defective or contaminated drugs reaching patients.
The multi-layer testing reduces the risk of manufacturing defects that often goes unnoticed. A single test may fail to detect contamination or improper formulation. Therefore, repeated testing across different laboratories increases accuracy and reliability.
It ensures accountability at every level of the supply chain, from manufacturers to distributors and hospital authorities. These are important in the case of critical medicines like injectables, antibiotics, and maternal care drugs. Where a minor quality issue can lead to severe complications or death.
Therefore, three layer testing builds public trust in government healthcare systems. Especially for patients relying on subsidized or free medicines often have limited alternatives. Therefore, it is essential that the drugs they receive comes with the highest safety standards.
Also Read: Building Sustainable Pharma Growth through Ethical Marketing Practices
In recent years, the number of such incidents has compelled the governments of India to enforce stricter drug control and surveillance measures throughout the country.
These cases have pointed to poor procurement and testing practices. Cases of cough syrups being contaminated and causing death, and others suspected to be faulty injections leading to maternal deaths.
A group of maternal deaths in Kota in Rajasthan came to the fore and caused concern across the country. Investigations have indicated that the problem may have been in the quality of the drugs or in the process of drug procurement.
These incidents came as a wake-up call to states to step up surveillance, boost inspections, and enhance laboratory facilities. The emphasis has shifted from reactive measures following a tragedy to systems that can detect risk at an early stage.
With respect to the recent tragedy, three-layer drug testing of the drugs has been adopted in Rajasthan. This is to ensure a higher standard of safety and quality.
The rule will make sure medicines undergo several checks before they can be approved for use in public health care facilities. This includes initial procurement, secondary verification, and further quality checks before distribution.
The government has also increased its scrutiny of manufacturers of the key drugs that were involved in the incident. These steps are taken to ensure the medicine quality is uncompromised within the healthcare system. And also will sent out the idea that the safety of patients is paramount.
As India continues to develop its pharmaceutical industry, it is crucial to take such steps to ensure that everyone can access the drugs without compromising on their quality. And ultimately, saving lives and gaining public trust are important in the healthcare delivery system.
.jpg)
